IBC Homepage

Meeting Agenda for 7/23/08

News from NIH

What's New?

FAQs

Forms

IBC Authority and Oversight

Recombinant DNA Categories

Registration

Extended Help for Registration

Biosafety Requirements & Resources

IBC Review/Approval & Meetings

Containment categories for commonly used agents

Human Subject Studies that Require IBC Approval

Policy on Vaccinia Virus

Printer friendly version of page

Vaccination with the vaccinia (smallpox) vaccine is recommended for all laboratory workers who will work directly with the agent. Each worker must be provided with access to the vaccine (available thru UHS). Each worker must also be provided with information about the pathogen and the vaccine, and advised of the possibility of vaccine failure or vaccine-related disease. Individuals who decline vaccination must provide their reason(s) on a signed form of declination. Until the individual has been immunized, or has signed a form declining immunization, he/she must not work with the agent.

Note -- The June 22, 2001 MMWR has a very helpful discussion on use of vaccinia vaccine among laboratory and health-care workers occupationally exposed to vaccinia virus, recombinant vaccinia viruses, and other Orthopoxviruses that can infect humans. See: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5010a1.htm.

• Smallpox (vaccinia) vaccine: consent/decline form
• Information regarding new Smallpox (Vaccinia) Live Vaccine (ACAM 2000)
• Comparison of ACAM2000 and DRYVAX
  
• Vaccine Overview
• People who should not get the vaccine
• Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001
• Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program